The genome editing is a technique used to precisely and efficiently add, remove or alter DNA in the genome by making cuts at specific DNA sequences with nuclease enzymes. Genome editing is mostly used in research, for treating diseases and in biotechnology.
The genome editing market is estimated to have a CAGR of 14.4% during the forecast period 2016-2023. The recent trend influencing the global genome editing market is the technological advancement in CRISPR technology. The CRISPR-Cas9 is a comprehensive form of gene editing and is expanding through biotech startups and laboratories globally. It has high potential in rectifying specific mutations in genome of human and in agriculture. Chinese scientists have recently started human clinical trials by using CRISPR-edited cell to cure lung cancer. The scientists have upgraded the CRISPR technology by editing the CRISPR systems such as CRISP RNPS. The benefits include reduced toxicity, improved specificity and better on-target efficiency and developing better therapeutic applications.
Current advances in genome editing are based on programmable nucleases that can amend eukaryotic genomes. The global genome editing market report includes the present and future scenario of the market with a detailed executive summary, including a market snapshot on different segments and sub-segments.
There are many factors such as high occurrence rate of transferable diseases and cancer among patients, advancement in technology, increasing government support & funding and growth in the number of genomics projects, rising demand for synthetic genes and rising awareness about genomics, are projected to drive the market in the future years. Rise in the production of genetically adapted crops is also projected to boost the demand for genome editing. Genome editing has many advantages and utilized in many applications but there are some factors such as high cost of genomic instruments and shortage of trained professional can hamper the growth of global genome editing market. 
Source: OBRC Analysis.
The report on global genome editing market is segmented into technology, application and end-user.
Technology is further segmented into:
- Genome Engineering CRISPR
- Genome Engineering Talen
- Genome Engineering Zen
- Genome Engineering Antisense
- Others
Application is further segmented into:
- Cell Line Engineering
- Animal Genetic Engineering
- Plant Genetic Engineering
- Other Application
End-user is further segmented into:
- Biotechnology & Pharmaceutical Companies
- Academic & Government Research Institutes
- Contract Research Organizations
The revenue for the above application and end-user segments are specific to global genome editing market. However, the total revenue of these application and end-user in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up technology segment.
The global genome editing market report is geographically segmented into:
- North America (U.S. & Canada)
- Asia Pacific (China, India, Japan, RoAPAC)
- Europe (UK, France, Germany, RoE)
- Rest of World
The global genome editing is segmented on the basis of technology, application, end-user and geography. Based on application, the market is segmented into plant genetic engineering, animal genetic engineering, cell-line engineering and others application. the cell line engineering division is anticipated to hold the highest share of the global market in 2016. A number of factors such as growing financial support from governments and personal organizations, increasing business focus on stem cell research, and rising global awareness about stem cell therapies through diverse organizations are pushing the growth of the cell line engineering applications segment. On the basis of technology, the genome editing market has been segmented into Clustered regularly-interspaced short palindromic repeats (CRISPR), Transcription activator-like effectors nuclease (TALEN), Zinc finger nuclease (ZFN), Antisense and other technology include recombinant AAV mediated genome editing. The CRISPR section is estimated to control the largest share of the global market in future years. The big market share and high growth rate of this technology sector can be credited to the simplicity of use associated with the technology and decrease in off-target effect of CRISPR. On The basis of end-user, the market is segmented into biotechnology & pharmaceutical companies, engineering academic & government research institutes and contract research organizations. The biotechnology & pharmaceutical companies section is expected to account for the largest share of the global market in the forecast years. Owing to number of factors such as the fast-growing aging population and the rising prevalence of transferable diseases and cancer are propelling the demand for genome editing market for biotechnology & pharmaceutical companies.
North America is expected to account for the major market share as well as the highest growth rate during the forecast period of global genome editing market, followed by Europe and Asia-Pacific. Owing to factors such as increasing use of genetically modified (GM) crops, dementia, occurrence of Alzheimer’s disease, transferable diseases, and high number of cancer cases, progress of gene therapy in the U.S.; rising research funding and grants and genome editing standards workshops & conferences are likely to boost the market in North America.
The major market players of the global genome editing market are:
- EDITAS MEDICINE
- GENSCRIPT USA INC
- ORIGENE TECHNOLOGIES, INC.
- SIGMA-ALDRICH CORPORATION
- OTHERS
These companies use various strategies such as merger & acquisition, collaboration, partnership and product launch. Whereas, merger & acquisition is the key strategy adopted by the companies in the genome editing market.
Example: In September 2016, Horizon Discovery Group, the world leader in the application of gene engineering technologies, collaborated with Fulcrum Therapeutics Inc., a US-based firm. The collaboration developed Horizon’s world-leading CRISPR-based screening platform to recognize new targets for regulating gene expression.
The report covers detailed analysis of companies which comprises of overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis in genome editing market.
Key reasons to buy the report:
- The report includes market estimation, forecast and analysis for the year 2016-2023
- Report includes detailed analysis of different segments such as application and end-user of genome editing.
- Identify and understand the strengths, opportunities, challenges and threat of global genome editing market.
- Covers details analysis of Porters 5 force model and other strategic models and also covers revenues, market share analysis, and competitive landscape analysis of major players of global genome editing market.
- Detailed analysis of various regulatory policies which affect the global genome editing market.
How we are different from others:
At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global genome editing market offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of the genome editing market, with giving extensive SCOT analysisof key companies.
Key findings of the global genome editing market:
- North America held highest revenue share in 2016.
- CRISPR segment of technology is expected to dominate the global genome editing market
- Cell line engineering is major segment of application.
- Biotechnology & Pharmaceuticals companies are expected to account largest share.
- Collaboration is the key strategy adopted by players of genome editing market.
